Suven Pharmaceuticals Fact Sheet, Suven Pharmaceuticals Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Suven Pharmaceuticals Fact Sheet    (SUVP)


Revealed: How Fund Managers Spot Winning Stocks


Here is the latest financial fact sheet of Suven Pharmaceuticals. For more details, see the Suven Pharmaceuticals quarterly results and Suven Pharmaceuticals share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUVEN PHARMACEUTICALS Price History

Price Rs 501.4
Mkt Cap Rs m 127,639
Vol '000 22.1
P/E X 41.4
P/CF X 43.6
EPS (TTM) Rs 12.1
% ch % 3.0
No. of shares m 254.57
% ch week % 7.6
% ch 1-mth % 4.5
% ch 12-mth % 72.2
52 week H/L Rs 565.0/285.5
(As on Jul 23, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUVEN PHARMACEUTICALS Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
SUVEN PHARMACEUTICALS EQUITY SHARE DATA
High RsNA353 
Low RsNA174 
Sales per share (Unadj.) RsNM65.5 
Earnings per share (Unadj.) RsNM21.1 
Diluted earnings per shareRsNM10.6 
Cash flow per share (Unadj.) RsNM23.0 
Dividends per share (Unadj.) Rs05.00 
Adj. dividends per shareRs0.002.50 
Dividend yield (eoy) %NM1.9 
Book value per share (Unadj.) RsNM66.4 
Adj. book value per shareRsNM33.2 
Shares outstanding (eoy) m0127.28 
Bonus / Rights / Conversions  -- 
Price / Sales ratio x04.0 
Avg P/E ratio x012.5 
P/CF ratio (eoy) x011.5 
Price / Book Value ratio x04.0 
Dividend payout %023.7 
Avg Mkt Cap Rs m033,533 
No. of employees `000NANA 
Total wages/salary Rs m296737 
Avg. sales/employee Rs ThNMNM 
Avg. wages/employee Rs ThNMNM 
Avg. net profit/employee Rs ThNMNM 
SUVEN PHARMACEUTICALS INCOME DATA
Net Sales Rs m3,7788,338 
Other income Rs m6181 
Total revenues Rs m3,7848,519 
Gross profit Rs m1,7163,851 
Depreciation Rs m115239 
Interest Rs m28231 
Profit before tax Rs m1,5793,563 
Minority Interest Rs m00 
Prior Period Items Rs m00 
Extraordinary Inc (Exp) Rs m00 
Tax Rs m486875 
Profit after tax Rs m1,0932,688 
Gross profit margin %45.446.2 
Effective tax rate %30.824.6 
Net profit margin %28.932.2 
SUVEN PHARMACEUTICALS BALANCE SHEET DATA
Current assets Rs m4,2285,111 
Current liabilities Rs m1,9073,198 
Net working cap to sales %61.422.9 
Current ratio x2.21.6 
Inventory Days Days18155 
Debtors Days Days14251 
Net fixed assets Rs m3,9337,812 
Share capital Rs m0127 
"Free" reserves Rs m5,7768,320 
Net worth Rs m5,7768,448 
Long term debt Rs m0913 
Total assets Rs m8,16112,923 
Interest coverage x57.616.4 
Debt to equity ratio x00.1 
Sales to assets ratio x0.50.6 
Return on assets %13.722.6 
Return on equity %18.931.8 
Return on capital %27.840.5 
Exports to sales %00 
Imports to sales %00 
Exports (fob) Rs m00 
Imports (cif) Rs m00 
Fx inflow Rs m01,481 
Fx outflow Rs m08,987 
Net fx Rs m0-7,506 
SUVEN PHARMACEUTICALS CASH FLOW
From Operations Rs m 504 4,160 
From Investments Rs m -655 -4,215 
From Financial Activity Rs m 260 64 
Net Cashflow Rs m 109 8 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 60.0%
Foreign collaborators 0.0%
Indian inst/Mut Fund 13.4%
FIIs 7.9%
ADR/GDR 0.0%
Free float 40.0%
Shareholders 92,669
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF #8-2-334 I S D E Serene Chambers, 6th Floor Road No. 5, Avenue 7 Banjara Hills , Hyderabad - 500034
E-MAIL info@suvenpharm.com WEB www.suvenpharm.com
TEL 040 - 2354 9414/ 3311/ 3315 FAX 040 - 2354 1152
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
YEAR OF INC: 2018 BSE CODE: 543064 FV (Rs): 1 DIV YIELD (%): 1.0

More Pharmaceuticals Company Fact Sheets:   TRIMURTHI DRUGS  SMS LIFESCIENCES INDIA  MERCURY LAB.  ABBOTT INDIA  SHREE GANESH REMEDIES   

Compare SUVEN PHARMACEUTICALS With:   TRIMURTHI DRUGS  SMS LIFESCIENCES INDIA  MERCURY LAB.  ABBOTT INDIA  SHREE GANESH REMEDIES   




Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

What Led to the Recent Surge in Shares of Thyrocare Technologies? (Views On News)

Jun 26, 2021

Shares of Thyrocare Technologies rallied over 7% and touched an all time high of Rs 1,465 on the BSE yesterday.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUVEN PHARMACEUTICALS

  • Track your investment in SUVEN PHARMACEUTICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS 8-QTR ANALYSIS

COMPARE SUVEN PHARMACEUTICALS WITH

MARKET STATS